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Twenty-five years have passed since the Chernobyl accident, but its health consequences remain to be well established. Fin-
land was one of the most heavily affected countries by the radioactive fallout outside the former Soviet Union. We analyzed
the relation of the estimated external radiation exposure from the fallout to cancer incidence in Finland in 1988–2007. The
study cohort comprised all ~3.8 million Finns who had lived in the same dwelling for 12 months following the accident (May
1986–April 1987). Radiation exposure was estimated using data from an extensive mobile dose rate survey. Cancer incidence
data were obtained for the cohort divided into four exposure categories (the lowest with the first-year committed dose <0.1
mSv and the highest 0.5 mSv) allowing for a latency of 5 years for leukemia and thyroid cancer, and 10 years for other can-
cers. Of the eight predefined cancer sites regarded as radiation-related from earlier studies, only colon cancer among women
showed an association with exposure from fallout [excess rate ratio per increment in exposure category 0.06, 95% confidence
interval (CI) 0.02–0.11]. No such effect was observed for men, or other cancer sites. Our analysis of a large cohort over two
decades did not reveal an increase in cancer incidence following the Chernobyl accident, with the possible exception of colon
cancer among women. The largely null findings are consistent with extrapolation from previous studies suggesting that the
effect is likely to remain too small to be empirically detectable and of little public health impact.
The nuclear power plant accident in Chernobyl on April 26,
1986, resulted in radiation exposure of several hundreds of
thousands of people of Belarus, Ukraine and South-Western
Russia in the vicinity of the reactor.1 In public health terms,
this is the largest radiation accident ever and the major chal-
lenge for radiation epidemiology in past decades. Approxi-
mately 115,000 people were evacuated from areas in the
vicinity of the plant with an average effective dose 31 mSv
during the 20 years after the accident.1 A total of 6.4 million
people residing in the contaminated areas (deﬁned as 137Cs
deposition >555 kBq/m2) were estimated to receive a mean
effective dose of 9 mSv during the same period.1 Notably, the
radiation dose to the thyroid from internal exposure to radio-
iodine was substantially higher, particularly among children.
The most important health effect of the accident has been
the dramatic, up to 5–10 fold increase in thyroid cancer in
the exposed population, primarily those exposed in child-
hood.1,2 More than 6,800 thyroid cancer cases have been
diagnosed in 1991–2005 among people aged <18 years at the
time of the accident in Belarus, Ukraine and south-western
parts of Russia.1 No consistent evidence of increases in other
cancer types has been found, though some reports have sug-
gested increases in leukemia and breast cancer.3–5 Among the
nearly 0.5 million clean-up workers involved in the recovery
operations, some suggestions of increased leukemia and thy-
roid cancer have been reported, but the evidence is not con-
clusive.6–9 The recent nuclear power plant accident in
Fukushima in Japan has heightened the interest on the issue
again.10
The research efforts have understandably concentrated on
the most heavily exposed populations including several hun-
dred thousand clean-up and recovery workers dispatched to
the area around the reactor in 1996–2001 (with mean doses
of the order of magnitude of 0.1 Sv), as well as the 5 mil-
lion residents of the contaminated areas (mean doses from
external radiation during the ﬁrst postaccident year close to 1
mSv) adjacent to the site in Belarus, Ukraine and some parts
of Russia. However, practically no systematic large scale stud-
ies with long-term follow-up have evaluated the cancer risk
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resulting from the low-level exposures outside the former
USSR.11 One should bear in mind that it also took several
decades to establish the excess risk of solid cancers among
Hiroshima and Nagasaki survivors.
No consistent evidence has been found for an increase in
cancer in more distant populations (outside Belarus, Ukraine
and south-west Russia) in the early studies.1 Some studies
have suggested increased cancer rates, but in most studies the
results have been negative.12–16 However, projections based
on theoretical calculations using the dose information, popu-
lation size and radiation risk coefﬁcients have suggested that
within the ﬁrst 20 years since the accident, besides the thy-
roid cancers, about 1800 other solid cancer cases could be
anticipated in the three most heavily exposed countries.17
Furthermore, in the other European countries with only
minor doses (<1 mSv), a similar number of excess cases
would be expected, due to the very large population exposed
(approximately 550 million). Yet, the attributable fraction
would remain very small (of the order of 0.01% for solid can-
cers and 0.05% for leukemia).17 However, as the expected
effects are very small, a large study population and accurate
exposure estimates would be needed even to exclude a risk
substantially larger than that predicted. Nevertheless, surveil-
lance of cancer incidence trends is warranted to assess the
full public health impact of the Chernobyl accident. For that
purpose, the absence of a detectable increase is informative,
even if the resolution would not be sufﬁcient for demonstrat-
ing very small effects.
The mean Cs-137 deposition from the Chernobyl fallout
in Finland was 12 kBq/m2, which is the highest outside the
former Soviet Union together with Austria and Slovenia.18
There was also variation within Finland, with about 12,000
km2 receiving deposition in excess of 37 kBq/m2.
The aim of our study was to perform cancer risk assess-
ment of the effect of radiation from Chernobyl fallout in Fin-
land, with estimation of the size of the possible effect.
Speciﬁcally, we divided the Finnish population into four
exposure strata and estimated cancer incidence trends during
1988–2007 in relation to radiation exposure from the
Chernobyl fallout. Exposure assessment was based on deposi-
tion in the country divided into four regions, separately for
houses and blocks of ﬂats. To enhance the validity of expo-
sure estimates, we restricted the analysis to those 3.8 million
subjects who had lived in the same residence in the ﬁrst
post-Chernobyl year (May 1986–April 1987), that is, during
the period when the most intensive radiation exposure
occurred.
Material and Methods
We conducted a cohort study of the residentially stable Fin-
nish population (3.8 million people, 90% of the total) iden-
tiﬁed from Statistics Finland, with internal comparisons
based on subdivision of the population into four exposure
groups. The study included all Finns, who resided in the
same dwelling between May 1986 and April 1987, that is, did
not move during the ﬁrst year after the Chernobyl accident.
This restriction was used to improve exposure assessment,
that is, maximize the variation between strata and minimize
it within them. No other inclusion or exclusion criteria were
applied.
Exposure assessment was based on Geiger-M€uller tube
and spectrometric measurements of dose rates from radioac-
tive caesium (134Cs and 137Cs). The measurements in 1,050
locations were performed in a mobile survey between May
1986 and August 1987.19 The contribution of all relevant
short-lived nuclides was determined from spectrometric
results. The effect of delay in the measurements was elimi-
nated by using a back-calculation technique that takes into
account both the radioactive decay and the washout effect.
The inﬂuence of fallout from atomic bomb tests in the 1950s
and 1960s was eliminated by calculating the calibration factor
from the 134Cs deposition. The population doses were mainly
caused by 137Cs and other volatile nuclides. Effective doses
from external radiation were estimated for each 8 3 8 km
square taking into account the deposition and the shielding
of buildings against radiation [depending on house type: 0.47
for houses (including detached, semidetached and terraced
houses) and 0.18 for blocks of ﬂats]. Four zones with con-
trasting patterns of deposition were deﬁned, to form dose
bands with equidistant cut-points (<0.10, 0.10–0.29, 0.30–
0.49 and 0.50 mSv during the ﬁrst postaccident year; Table
1). Other sources of radiation exposure (mainly from natural
sources and medical uses of radiation) were assumed to have
changed in a similar fashion in each area after the accident
(i.e., result in nondifferential misclassiﬁcation).
Aggregate data on cancer incidence for small area units
consisting of 250 3 250 m and covering all of Finland were
used. The numbers of person-years (denominator data) were
obtained for each square from Statistics Finland by 5-year
age group, sex, house type and socioeconomic status (SES)
What’s new?
While radiation exposure from the 1986 Chernobyl accident led to dramatic increases in thyroid cancer among people living
within the vicinity of the reactor, health consequences for populations outside the former Soviet Union remain unclear. Here,
the effect of Chernobyl fallout over a period of nearly 20 years in Finland was investigated using individual-level residential
and cancer data. Only a single malignancy, colon cancer in women, was found to be associated with radiation exposure from
the accident. The findings support current thinking that the possible impact on cancer incidence at the population level is
likely to remain small.
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based on occupation and education from the Population
Census 1985 (classiﬁed as: farmers, foresters, ﬁshermen; other
employers and self-employed persons; upper clerical workers;
lower clerical workers; skilled manual workers; unskilled
manual workers and others).
The 459,622 cancer cases that 1987–2007 in the study
cohort (numerator data) from the Finnish Cancer Registry
were linked in the Statistics Finland by personal identity code
with the data on sex, age, place of residence (in May 1986),
house type and SES. An anonymized database with numbers
of cases for 250 3 250 m map squares was generated for the
analysis.
The exposure strata were of uneven size, the lowest com-
prising more than half of the study population (59%) and the
highest only 4% (Table 2 and appendix Tables A1–A3). The
numbers of person-years for the three lowest exposure strata
in each ﬁve-year period ranged from 11 million to 1.7 million
(men and women, houses and blocks of ﬂats combined), but
were substantially smaller for the highest exposure group
(640,000–540,000 both sexes, houses and blocks of ﬂats com-
bined, Table 2). Due to the lower exposure levels in blocks of
ﬂats, the highest exposure group included practically only
people living in houses (Figs. 1a and 1b). Consequently, no
cancer cases were observed in the highest exposure group
residing in blocks of ﬂats (Table 3). For the other strata, the
median number of cases for the second highest exposure
group was 10 for blocks of ﬂats for both men and women
and was substantially larger for the strata with lower expo-
sure. Therefore, analyses were conducted for houses and ﬂats
combined and separately for houses.
In the analysis by cancer site, we concentrated on cancer
types strongly associated with radiation in previous studies
(leukemia, cancers of the ovary, oesophagus, colon, breast,
bladder, stomach and thyroid cancers), but also included
some “control” sites not consistently associated with radiation
in earlier studies (lymphomas, rectal and pancreatic cancer).
A meaningful analysis of childhood leukemia was not possi-
ble due to the small numbers of cases at follow-up (18 cases
in 1998–2002 and two in 2003–2007).
The numbers of cancers and person-years at risk were
stratiﬁed by gender, age attained, SES and house type. A
minimum latency period of ﬁve years was assumed for leuke-
mia and thyroid cancer and 10 years for other sites. Thus,
the calendar period 1988–1997 was considered the latency
period unaffected by the fallout (and used only in the base-
line trend and level evaluation) for most cancer types, with
Table 1. Exposure categories used in the analysis (dose conversion
shown for houses)
Exposure
category
Cs-137
deposition
(kBq/m2)
Effective
dose1
(mSv)
Population
size2
1 <9 <0.1 2,255,716
2 9–27 0.1–0.29 1,070,873
3 28–45 0.3–0.49 350,584
4 46 0.5 132,551
1Dose from external radiation for inhabitants of houses during the first
postaccident year (May 1986–April 1987).
2Numbers of subjects at start of follow-up (houses and blocks of flats,
men and women, all age groups combined).
Figure 1. Dose distribution from the Chernobyl fallout in Finland for people residing in (a) houses and (b) blocks of flats.
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the postlatency period starting from 1998, but a shorter
latency period (1988–1992) was applied for leukemia and
thyroid cancer.
The number of cancer cases was described by the Poisson
distribution, where the logarithm of the incidence rate k was
modelled as a linear function of attained age (i, ﬁve-year age
groups up to 84 and 85 years), SES (s), calendar year (v)
and exposure group (e, e5 1, if exposure< 0.1 mSv; e5 2, if
0.1 exposure< 0.3; e5 3, if 0.3 exposure< 0.5; and e5 4,
if exposure 0.5). In the main analysis, also house type (h,
houses and blocks of ﬂats) was used, but an additional analy-
sis included only houses. The main model can be written as:
log kishev5ai1gs1dh1Ee1bv1seIv
where the period of observation was divided into the latency
and post-latency period using an indicator variable Iv that
equals 1 in the period beyond latency time and 0 otherwise.
In the main model (illustrated for the two lowest exposure
groups in Fig. 2, left panel), the slope b of the logarithm of
the incidence rate was assumed to be the same in all the
exposure strata. In addition, an alternative model (Fig. 2,
right panel) where be is estimated separately for each expo-
sure group e (instead of a common b), allowing the slopes of
the logarithms of the incidence rates to vary between the
exposure groups, was ﬁtted. In both models, rate ratio
(RRe)5 exp(se) is the RR between the incidence rate in expo-
sure group e in the postlatency period and the expected one
that would have been observed, if the intercept of the loga-
rithm of the incidence rate remained unchanged after the
latency period. To test for the trend in the RRs the effect of
the increasing exposure was modeled using a numerical expo-
sure variable e such that se5 s11 c(e2 1). In the models
with the numerical exposure variable, excess rate ratio
(ERR)5 exp(c)2 1 is the excess RR per an increasing expo-
sure unit, that is, the RRs in exposure groups 2, 3 and 4 are
exp(c), exp(2c) and exp(3c)-fold, respectively, as compared
with the RR in exposure group 1. The four models (main
and alternative model, both with categorical and numerical
exposure) were compared, and the heterogeneity and the
trend in the RRs were tested using the likelihood ratio test.
A permission to use the cancer registry data was issued by
the National Institute for Health and Welfare. The ethical
committee at STUK–Radiation and Nuclear Safety Authority
was informed of the study protocol. No conﬁdentiality issues
arose, as no individual-level data were used and the units of
observation were too large for identifying individuals.
Results
The study covered more than 15 million person-years of
observation during each 5-year period (Table 2 and appendix
Tables A1a–A3b), with more than 400 cancer cases by period
for each studied cancer site when all exposure categories,
men and women and both house types were combined
(Table 3). For the analysis restricted to houses, the overall
numbers were smaller by approximately a half, but the num-
bers in the highest exposure groups were hardly diminished.
Of the six cancer types analyzed in both sexes and the
two female cancer sites a priori selected as potentially
radiation-induced, only colon cancer among women showed
an association with the level of exposure from the Chernobyl
fallout (Table 4). In the trend analysis of the entire cohort
across the four exposure groups, the ERR for female colon
cancer per increment in exposure category was 0.06 (95% CI
0.02–0.11), that is, the RR in the highest exposure group was
1.0632 15 19% larger than that in the lowest exposure
group. Alternatively, this result across the four exposure
groups can be interpreted as 1.19-fold increase in incidence
in the highest exposure stratum, with the lowest exposure
group as reference, after the latency period. In the highest
exposure group, an incidence rate ratio (RR) of 1.11 (95% CI
0.90–1.37) was found for female colon cancer, that is, a 11%
increase in the observed relative to the expected incidence
rate for the highest exposure group after the latency period.
An analysis limited to houses (with higher exposure and less
Table 2. Numbers of person-years by sex, period, house type and exposure category (first year dose, mSv)
Men Women
1988–1992 1993–1997 1998–2002 2003–2007 1988–1992 1993–1997 1998–2002 2003–2007
Houses
<0.1 mSv 2,994,300 2,839,864 2,677,365 2,521,231 2,909,381 2,781,300 2,640,070 2,501,507
0.1–0.29 mSv 1,974,224 1,863,738 1,752,072 1,645,296 1,951,142 1,853,280 1,748,575 1,646,706
0.3–0.49 mSv 797,780 750,157 701,830 656,443 785,416 744,161 700,046 656,780
0.5 mSv 325,330 307,374 288,876 270,741 322,566 306,625 289,488 272,674
Blocks of flats
<0.1 mSv 2,273,939 2,136,768 2,000,659 1,887,609 2,833,619 2,651,250 2,458,032 2,313,824
0.1–0.29 mSv 573,176 534,008 496,088 464,356 721,682 670,017 614,803 573,926
0.3–0.49 mSv 58,836 55,696 52,454 49,581 68,652 64,979 61,099 57,602
0.5 mSv 25 25 21 20 15 15 15 15
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variation than in blocks of ﬂats) showed largely comparable
results for female colon cancer (RR5 1.03 for the highest
exposure group, CI 0.83–1.28, Table 4). No such association
was found among men (RR5 1.03, 95% CI 0.98–1.08 for
trend across exposure categories and RR5 1.06 for the high-
est exposure group). A weak, non-signiﬁcant positive relation
was observed also for female thyroid cancer, with a similar
ﬁnding observed in the analysis restricted to houses, but little
evidence for such relation among men.
None of the sites previously showing no consistent associ-
ation with radiation exposure (“control sites”) was associated
with the level of exposure. Very little variation with exposure
was found for rectum and pancreas cancers, and Hodgkin
lymphoma showed a weak positive association with exposure
level.
The main model provided a better ﬁt for all cancer sites
except ovary. The alternative model that did not assume pro-
portional incidence trends between the exposure groups dur-
ing the latency and postlatency periods within each exposure
group, that is, did not assume the same be for all exposure
groups (illustrated in Fig. 2, right panel), provided a better ﬁt
for ovarian cancer. The results of these analyses were qualita-
tively similar in that they did not show an increase in rela-
tion to exposure level. The RR point estimates varied more
across the exposure groups and point estimates for the ERR
deviated more from zero in the analysis based on the alterna-
tive model (results not shown).
A population-based colorectal cancer screening program
was launched in Finland gradually from 2004 onwards, and
the areas ﬁrst covered where in the regions that were mainly
in the highest exposure category. The observed effect for
female colon cancer was not substantially affected by limiting
the analyses to the period prior to introduction of screening
(up to the year 2003) or excluding the target age group or
municipalities where screening was introduced (ERR5 0.07,
95% CI 0.02–1.12 for houses and block of ﬂats, ERR5 0.09,
95% CI 0.03–0.15 for houses only).
Analyses with a shorter 5-year latency for solid cancers
gave largely consistent results, but the risk related to
female colon cancer was smaller and no longer signiﬁcant
(RR across the four categories 1.04, 95% CI 0.98–1.10 and
RR in the highest exposure group 0.97, with similar ﬁnd-
ings in analysis restricted to houses only). In addition, a
positive association emerged with female breast cancer
(RR5 1.04, 95% CI 1.01–1.07 across the four categories
and RR5 1.18 in the highest exposed group) and an
inverse association between radiation exposure and non-
Hodgkin lymphoma in men (both in the entire material
and houses only).
An analysis by age at exposure was also conducted and
showed no evidence of effect modiﬁcation for the sites previ-
ously associated with radiation (all likelihood ratio p-values
>0.2 for an interaction term of age and exposure), though
the numbers of cases in the age group 0–19 years were so
small that the statistical power was low (<10 cases in the
highest exposure group in all 5-year periods in each site,
except breast and Hodgkin disease <20 cases).
Discussion
We found little evidence overall for an increased incidence of
cancer in relation to Chernobyl fallout in Finland with a
study design using individual level residential and cancer
data combined with area-level exposure assessment. Even
though our results can exclude only an effect several orders
of magnitude larger than anticipated, they can be regarded as
informative for evaluation of the public health impact of the
Chernobyl accident and contributing to knowledge about the
health consequences of the Chernobyl accident. The strengths
of the study include a reasonably long observation period of
20 years, large study population of nearly four million people
Figure 2. A schematic representation of the statistical models applied in the data analysis for the two lowest exposure groups. e: exposure
group, tau: change in log incidence rate from the latency to the post-latency period.
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and consideration of other factors, such as SES, house type
and residential stability.
Only the analysis of colon cancer among women showed
an association between radiation exposure and incidence in
the postlatency period. A similar ﬁnding was also seen in the
subset of people residing in houses, but no such result was
observed for men. A possible confounding factor was colo-
rectal cancer screening with occult fecal blood test introduced
in Finland during the study period, and it was ﬁrst com-
menced in the area mainly belonging to the highest exposure
group, with gradual extension to cover 40% of the country by
2008.20 Restricting the analysis to the unscreened population
(in terms of area or age group, or period) did not materially
affect the ﬁndings, which indicates that the result was not
due to screening. Other potential confounding factors include
dietary factors (fruit and vegetables/ﬁber vs. fat), physical
exercise (obesity), alcohol, smoking, NSAIDs, menopausal
hormone use. We had no information on them, but they
would confound the results only if changes occurred in them
contemporaneously with the fallout and with a similar geo-
graphical pattern.
The effect size corresponds to a 1.19-fold increase in the
highest exposure group relative to the lowest. The committed
effective doses from external radiation over 20 years can be
Table 4. Incidence rate ratios (RRs) between the incidence rates in the postlatency period 1998–2007 (1993–2007 for leukemia and thyroid)
and the expected ones based on the trends in 1988–1997 (1988–1992 for leukemia and thyroid) by sex, house type, cancer site and expo-
sure category (RR1 for the lowest exposure category and RR4 for the highest)
Men Women
RR1 RR2 RR3 RR4 ERR, % 95% CI RR1 RR2 RR3 RR4 ERR 95% CI
Blocks of flats and houses
Sites associated with radiation
Leukemia 0.96 1.01 0.98 0.88 0 (29, 9) 1.09 1.11 1.02 0.99 22 (211, 7)
Breast – – – – 1.03 1.07 1.04 1.11 2 (20.4, 4.0)
Ovary – – – – 0.87 0.91 0.99 0.91 4 (22, 10)
Esophagus 1.13 1.04 1.35 1.43 6 (25, 17) 0.98 0.89 0.94 0.73 27 (218, 7)
Colon 0.94 1.07 0.90 1.06 3 (22, 8) 0.96 1.03 1.09 1.11 6 (2, 11)
Bladder 0.96 0.96 0.89 0.91 22 (27, 3) 1.00 1.06 1.08 1.17 5 (24, 16)
Stomach 0.93 1.00 0.95 1.03 3 (22, 9) 1.02 1.03 1.09 1.04 2 (24, 9)
Thyroid 1.34 1.18 1.50 1.16 21 (217, 18) 1.12 1.30 1.25 1.35 8 (22, 19)
Sites not associated with radiation
Hodgkin lymphoma 0.73 0.71 0.74 0.93 3 (211, 19) 0.97 1.40 1.47 0.95 15 (22, 35)
Non-Hodgkin lymphoma 0.94 0.97 0.97 0.82 0 (26, 6) 0.96 1.01 1.13 0.94 4 (22, 11)
Rectum 0.98 0.99 1.01 0.91 0 (26, 6) 0.93 0.90 1.02 0.86 0 (27, 7)
Pancreas 0.98 0.91 0.92 1.09 21 (27, 5) 0.95 0.99 0.99 0.81 0 (26, 6)
Houses only
Sites associated with radiation
Leukemia 1.00 0.96 1.07 0.89 21 (210, 10) 1.05 1.11 0.96 0.98 22 (213, 9)
Breast – – – – 1.01 1.08 1.02 1.09 2 (21, 5)
Ovary – – – – 0.84 0.84 0.97 0.87 4 (23, 11)
Esophagus 1.24 1.00 1.40 1.50 4 (28, 17) 0.90 0.84 0.98 0.75 22 (217, 15)
Colon 0.94 1.02 0.88 1.03 1 (25, 7) 0.88 0.99 1.04 1.03 8 (2, 14)
Bladder 0.93 0.91 0.87 0.88 22 (28, 3) 1.07 1.17 1.10 1.22 4 (28, 16)
Stomach 0.93 0.98 0.93 1.02 2 (24, 8) 1.07 1.06 1.09 1.04 0 (27, 8)
Thyroid 1.30 1.22 1.52 1.16 1 (217, 24) 1.13 1.26 1.36 1.35 8 (23, 21)
Sites not associated with radiation
Hodgkin lymphoma 0.74 0.73 0.76 0.96 5 (211, 23) 1.25 1.53 1.67 1.03 5 (213, 26)
Non-Hodgkin lymphoma 1.02 1.05 0.99 0.84 23 (210, 3) 0.91 1.01 1.10 0.92 6 (22, 14)
Rectum 0.98 1.03 1.00 0.90 21 (27, 6) 0.92 0.96 1.05 0.86 2 (26, 11)
Pancreas 1.01 0.90 0.94 1.09 21 (28, 6) 0.94 0.96 0.98 0.78 21 (28, 6)
Excess RRs (ERR, %) per incremental exposure category are also shown.
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roughly estimated as <1 mSv in the lowest versus 5 mSv in
the highest exposure category. This corresponds roughly to
an ERR of 0.04 per mSv or 40 per Sv, which is clearly incon-
sistent with for instance the results of the Life Span Study of
the atomic bomb survivors (ERR 0.5 per Sv for colon can-
cer),21 which is considered the most important source of
information regarding long-term health effects of ionizing
radiation. Further, colon was one of the few cancer sites with
a higher risk coefﬁcient for men than women among the
atomic bomb survivors.
This ﬁnding could also be attributable to chance, which is
also credible given that 14 site and gender strata were ana-
lyzed as a priori radiation-related (the probability of detecting
at least one statistically signiﬁcant ﬁnding out of 14 tests by
chance alone is 12 0.95145 0.51, provided that the compari-
sons are independent). Yet, none of the four cancer sites with
little previous evidence of being radiation-induced (used as
“negative controls”) showed an association with the exposure.
A quarter of a century has passed since the Chernobyl
accident. Nevertheless, the health effects remain to be charac-
terized in detail and we are only approaching the stage, when
large scale data about cancer incidence following the latency
period become available. To some extent, this is attributable
to the low doses and consequently small increases in morbid-
ity, strongly limiting the possibilities of epidemiological stud-
ies to detect an increase—or exclude an effect of the size
predicted from other studies. The typical cumulative effective
doses (0.3 mSv for 1986–2005) for the Western European
populations were comparable to a single radiographic exami-
nation such as two projections in mammography or three
chest x-rays with two projections and less than the dose from
a single CT scan.1
The expected magnitude of effects can be extrapolated
from the results of studies on higher doses. Among the
atomic bomb survivors, the effect size for solid cancers have
been approximately ERR 0.5 per Sv.21 The mean committed
effective dose in 1986–2005 for the Finnish population has
been estimated as 1.4 mSv1, and for the highest exposure
group in this study, the committed effective dose is likely to
be of the order of magnitude of 5 mSv (given that the ﬁrst-
year dose in this group was 3.5-fold higher than the
population-weighted mean dose in the entire population).
This is a crude assessment relying on the assumption that
due to the lower contribution of short-lived radioisotopes in
Finland, the dose committed during the 20-year period was
3–5 times the ﬁrst-year dose, while the corresponding ratio
for the areas close to the accident site estimated as three by
UNSCEAR. Such dose would translate into an excess cancer
incidence of <0.05% (RR of <1.0005), assuming similar
effect per dose unit as among atomic bomb survivors (despite
differences in exposure features such as dose rate and contri-
bution of internal exposure). The nominal risk coefﬁcient
proposed by the International Commission for Radiological
Protection (lifetime absolute risk of 5.5 3 1022 for cancer
death) can also be used to obtain a crude measure of the
anticipated effect. Applying this ﬁgure to the collective dose
in the cohort (500 person-sievert for the ﬁrst-year dose, up
to 2000 person-sievert taking into account internal exposure
and long-term committed dose) would give 30–120 addi-
tional cancer deaths over a period of some 50 years. For can-
cer incidence, the ﬁgures would be higher by a factor of
three, but still only a tiny fraction of the background risk.
Such effects are likely to remain below the threshold of
detectability for any epidemiological study.
Our results are consistent with the majority of earlier
studies assessing the effect of the Chernobyl fallout on cancer
incidence in Europe.12–16 The ﬁndings are in contrast with
those reported from Sweden suggesting an early increase in
cancer incidence22 (although the study periods do not over-
lap). That study reported an increase in overall cancer inci-
dence in the area most heavily affected by the Chernobyl
fallout in 1988–1999. The authors interpreted the ﬁndings as
indicating a promotion effect, but the approach has been
criticized for methodological shortcomings, including ignor-
ing underlying trends and prior differences in rates. Based on
the results of the studies on Hiroshima and Nagasaki atomic
bomb survivors, the increase in solid cancer risk is expected
to remain elevated for at least 2–3 decades since its ﬁrst
emergence, though with some attenuation.21
Our study has notable advantages compared with earlier
ones. We were able to establish a nation-wide cohort of
population remaining resident in the same dwelling for the
time period when the most intensive exposure took place,
which improved the validity. The dose rate at 12 months
from the accident was only about one tenth of the initial
level. In addition, the follow-up for cancer incidence was
conducted at individual level and therefore cases (as well as
person-years) were allocated to the correct exposure group
regardless of subsequent eventual moving, which avoids
misclassiﬁcation and ecological fallacy. The large size of the
study population and long follow-up enhanced the statistical
power, though in respect to the anticipated effect size it
remained modest.
Some obvious limitations, however, restrict the conclu-
sions. Ideally, exposure assessment would be performed using
personal dosimeters for external dose and whole body count-
ing for internal exposure. This is, however, clearly not feasi-
ble for any population of meaningful size for epidemiological
studies. External dose is a function of the deposition, with
modiﬁcation by protection afforded by shielding of the build-
ings. The deposition can be expected to remain reasonably
homogenous within the area units of 8 3 8 km, compared
with large geographical units used in previous studies. Shield-
ing was accounted for by the proportion of single-family
houses and other low-rise residential buildings within a
square. The shielding factor for radiation due to fallout was
deﬁned as the ratio of the dose rate indoors to the outdoor
dose rate. This gives typical values for the small area, though
with some misclassiﬁcation due to aggregation to group level.
Further variation that we could not account for was due to
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occupancy (time spent indoors) and exposure outside the
home (both at work and during leisure time, including time
spent in other buildings and travel outside the home district).
Even if we had to resort to averaging over a small area with
group-level data, we were able to use smaller units of obser-
vation in exposure assessment than in any earlier epidemio-
logical study on the health effects of Chernobyl fallout.
Therefore, dilution owing to non-differential exposure mis-
classiﬁcation should have less effect in our study.
We did not have information on internal radiation expo-
sure, which resulted mainly from ingestion of food stuffs
contaminated by radionuclides, primarily caesium-137. In
the area with the highest fallout, milk products and ﬁsh
were the most important sources, and elsewhere also meat
and eggs.23 Radioiodine did not contribute substantially, as
much of it decayed already before reaching Finland due to
its short half-life, and intake through milk was also reduced
by the fact that the cows were not yet out on pastures in
Finland at the time of the accident.23 The internal dose was
0.3 mSv for the ﬁrst year in the entire population (and
below 0.5 mSv even in the areas with the highest fallout),
and declined rapidly thereafter.24 The mean committed
effective dose from ingestion of radionuclides from the
Chernobyl fallout for the Finnish population during 1986–
2005 has been estimated as 1 mSv.23,24 The internal dose
was correlated with external radiation dose, but with less
marked contrast between areas due to the fact that most
consumed food is not produced locally.12 If incremental
dose from internal exposure, which is correlated with the
external dose but has less steep gradient across the popula-
tion, is taken into account in the dose-response analysis, it
would increase the constant (exposure level in the reference
category), but slightly ﬂatten exposure contrast and hence
observed the slope (regression coefﬁcient) could slightly
underestimate the true exposure-effect gradient.
Obviously, individual-level information on the major life-
style determinants of cancer risk would have been desirable
for control of confounding, as in any epidemiological study.
Such data were unavailable in our study and we are unaware
of any cohorts of this size with such information. We were,
however, able to control for the effects of age, sex, SES and
house type. Besides confounding, other sources of radiation
exposure may cause exposure misclassiﬁcation, which can
mask an effect. However, in our longitudinal study, differen-
ces between exposure groups that remained unchanged would
not bias the results, as they are incorporated in the underly-
ing trend (of the background incidence rates). Therefore, for
instance differences in natural background radiation between
exposure groups would not affect our ﬁndings. Only system-
atic differences in relation to fallout over time (i.e., diverging
trends in exposure from other sources) could bias the ﬁnd-
ings related to the effects of the fallout.
In conclusion, we were unable to demonstrate an increase
in cancer incidence in Finland related to the fallout from
Chernobyl. We were able to construct sub-groups with a rela-
tive exposure contrast by a factor of ﬁve, but the absolute dif-
ferences in radiation doses were very small and the overall
dose level was low. The strengths of the study include larger
size and longer follow-up than in earlier studies, as well as
restriction to a residentially stable cohort, which improved
exposure estimation. However, we could not exclude a small
effect of the size expected on the basis of existing risk esti-
mates (of the order of magnitude of 1% increase in cancer
incidence), as the statistical power was limited by the low
exposure levels.
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